In today's security landscape, some of the most dangerous vulnerabilities aren't flagged by automated scanners at all. These ...
Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
1don MSN
Re-engineered human cells boost gene-editing particle potency across multiple delivery systems
Gene editing has emerged as a powerful approach for targeting the genetic causes of disease, but getting the editing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results